Nebenwirkungen · Tepadina
TEPADINA 15 mg powder for concentrate for solution for infusion TEPADINA 100 mg powder for concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 9
HOS-210399 · Präparat HOS-154509
Infections and Infection Toxic shock infestations susceptibility syndrome increased Sepsis Neoplasms Treatment related benign, second malignant and malignancy unspecified (incl cysts and polyps) Blood and Leukopenia lymphatic Thrombocytopeni system a disorders Febrile neutropenia Anaemia Pancytopenia Granulocytopenia Immune Acute graft versus Hypersensitivity system host disease disorders Chronic graft versus host disease Endocrine Hypopituitarism disorders Metabolism Anorexia and nutrition Decreased disorders appetite Hyperglycaemia Psychiatric Confusional state Anxiety Delirium disorders Mental status Nervousness changes Hallucination Agitation Nervous Dizziness Intracranial Leukoencephalopath system Headache aneurysm y disorders Vision blurred Extrapyramidal Encephalopathy disorder Convulsion Cognitive disorder Paraesthesia Cerebral haemorrhage Eye disorders Conjunctivitis Cataract
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-02-24T14:00:00Z · SHA-256 42c8bab87a55159cb982d55f577a064273549ce149f75b75dbf4d5650be413bc · Passage 8356f1d8a6d931ab9a8bf5c27b5185b016f42c0df1139d36b7a23140db6817fa · Zeichen 1989–3772 im Abschnitt